- Home
- Products
- Customized FluoroAb™
- CD40
- Anti-CD40 MAb (Clone 6)-iFluor® 546 Succinimidyl Ester
Anti-CD40 MAb (Clone 6)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15018)
This product is comprised of an Humanized Anti-CD40 Fab'-G1-kappa (Clone 6) labeled with iFluor® 546 Succinimidyl Ester. iFluor® 546 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CD40
- Alternative Names
- CD40; CD40 molecule; TNF receptor superfamily member 5; TNFRSF5; tumor necrosis factor receptor superfamily; member 5; tumor necrosis factor receptor superfamily member 5; Bp50; p50; CD40L receptor; CD40 type II isoform; B cell-associated molecule; B cell surface antigen CD40; B-cell surface antigen CD40; CD40 antigen (TNF receptor superfamily member 5); tumor necrosis factor receptor superfamily; member 5; nerve growth factor receptor-related B-lymphocyte activation molecule; CDW40; TNFRSF5; MGC9013;
- Overview
- This gene is a member of the TNF-receptor superfamily. The encoded protein is a receptor on antigen-presenting cells of the immune system and is essential for mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. AT-hook transcription factor AKNA is reported to coordinately regulate the expression of this receptor and its ligand, which may be important for homotypic cell interactions. Adaptor protein TNFR2 interacts with this receptor and serves as a mediator of the signal transduction. The interaction of this receptor and its ligand is found to be necessary for amyloid-beta-induced microglial activation, and thus is thought to be an early event in Alzheimer disease pathogenesis. Mutations affecting this gene are the cause of autosomal recessive hyper-IgM immunodeficiency type 3 (HIGM3). Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
- Overview
- Humanized Anti-CD40 Fab'-G1-kappa (Clone 6)
- Species Reactivity
- Human
- Name
- iFluor® 546 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 541/557
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-FN1 MAb (Clone 3)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5112)
- Anti-MYL MAb (Clone 3)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS6218)
- Rilotumumab-iFluor 750 (CAT#: ADC-FL-1595)
- Anti-PDCD1 MAb (Clone 14)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16841)
- Anti-SLAMF6 MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5005)
- Anti-TAG-72 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS725)
- Anti-TNFRSF10B MAb (Clone 11)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8668)
- Anti-Pseudomonas aeruginosa serotype IATS O11 MAb (Clone 1)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8423)
- Anti-HBV surface antigen MAb (Clone 3)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1561)
- Anti-TNFSF11 MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14608)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS15018. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-899 | Anti-CD40 (Dacetuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-910 | Anti-CD40 (Lucatumumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-912 | Anti-CD40 (Lucatumumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-904 | Anti-CD40 (Teneliximab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-913 | Anti-CD40 (Lucatumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.